The Food and Drug Administration (FDA) has approved Journavx™ (suzetrigine) for the treatment of moderate to severe acute pain in adults.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

The U.S. Food and Drug Administration said it approved Vertex Pharmaceuticals’ Journavx for short-term pain that often ...

Meloxicam is a nonsteroidal, anti-inflammatory molecule developed with Axsome’s Molecular Solubility Enhanced Inclusion ...

The Food and Drug Administration (FDA) has approved a new maintenance dosing schedule for Leqembi, a monoclonal antibody ...

Invizyne Technologies, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug ...

A former NFL football player. These are among the first 100 people who President-elect Donald Trump has named to various positions for his upcoming administration. To examine who will be in Trump ...

Cited projections do not guarantee actual salary or job growth. Thinking about earning a degree? You may have seen "business administration" listed as a possible major. But what exactly does business ...

Too much of anything can be bad, and the consequence of too much of drugs is something we are all familiar with. Not all of us have tried these drugs, but cinema has shown us the most graphic and ...

Strattera is the first nonstimulant medication approved by the Food and Drug Administration (FDA) to treat ADHD. It is a selective norepinephrine reuptake inhibitor (SNRI). A person usually takes ...

Even quaint corners of the country are seeing a rise in drug violence and crime ... working with both the Biden administration’s envoy and a representative for Donald Trump, formed an unlikely ...